SCHEMBL21985272

SCHEMBL21985272

CC(C)/C(N)=C/NCC(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.44
CYP2D6 P10635 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
PTGS2 P35354 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
ECE1 P42892 1/20 0.32
MME P08473 1/20 0.32
ACE P12821 1/20 0.32
CPA1 P15085 1/20 0.32
ACE2 Q9BYF1 1/20 0.32
GABRP O00591 2/20 0.31
GABRD O14764 2/20 0.31
GABRA1 P14867 2/20 0.31
GABRB1 P18505 2/20 0.31
GABRG2 P18507 2/20 0.31
GABRB3 P28472 2/20 0.31
GABRA5 P31644 2/20 0.31
GABRA3 P34903 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4525716 0.73 ALDH1A1 (0.47) ALDH1A1CYP2D6SMN1; SMN2LMNAMAPT
SCHEMBL4525715 0.73 ALDH1A1 (0.47) ALDH1A1CYP2D6SMN1; SMN2LMNAMAPT
SCHEMBL13637008 0.72 ALDH1A1 (0.46) ALDH1A1CYP2D6SMN1; SMN2CTH
SCHEMBL21308279 0.71 ALDH1A1 (0.41) ALDH1A1CYP2D6SMN1; SMN2LMNAMAPT
SCHEMBL20156652 0.70 ADH1B (0.37)
SCHEMBL7069815 0.67
SCHEMBL11521413 0.67
SCHEMBL4532391 0.67 ALDH1A1 (0.44) ALDH1A1CYP2D6SMN1; SMN2LMNAMAPT
SCHEMBL4532387 0.67 ALDH1A1 (0.44) ALDH1A1CYP2D6SMN1; SMN2LMNAMAPT
SCHEMBL22702133 0.66 ADH1B (0.46) ALDH1A1SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3478674-B1 4,6-DIAMINOQUINAZOLINES AS COT MODULATORS AND METHODS OF USE THEREOF GILEAD SCIENCES INC (US) 2020-05-13 EP disclosed